SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Donald F. Kirby, Soumya Chatterjee, Evaluation and management of gastrointestinal manifestations in scleroderma, Current Opinion in Rheumatology, 2014, 26, 6, 621

    CrossRef

  2. 2
    Carla Maradey-Romero, Scott Gabbard, Ronnie Fass, Treatment of Esophageal Motility Disorders Based on the Chicago Classification, Current Treatment Options in Gastroenterology, 2014, 12, 4, 441

    CrossRef

  3. 3
    Rene Thonhofer, Cornelia Siegel, Markus Trummer, Winfried Graninger, Early endoscopy in systemic sclerosis without gastrointestinal symptoms, Rheumatology International, 2012, 32, 1, 165

    CrossRef

  4. 4
    Genevieve Gyger, Murray Baron, Gastrointestinal Manifestations of Scleroderma: Recent Progress in Evaluation, Pathogenesis, and Management, Current Rheumatology Reports, 2012, 14, 1, 22

    CrossRef

  5. 5
    Ghaith Noaiseh, Sophia Li, Chris T Derk, Management of gastrointestinal manifestations in systemic sclerosis (scleroderma), International Journal of Clinical Rheumatology, 2012, 7, 6, 661

    CrossRef

  6. You have free access to this content6
    André Smout, Mark Fox, Weak and absent peristalsis, Neurogastroenterology & Motility, 2012, 24,
  7. 7
    Steven D. Waldman, Pain Management, 2011,

    CrossRef

  8. 8
    Kunio Kawanishi, Minako Koike, Kazuo Kimura, Yuko Sasaki, Masaki Takahashi, Keiko Matsugami, Noriaki Nakagawa, Masayuki Nakano, Takashi Takei, Kousaku Nitta, An autopsy case of untreated systemic sclerosis with renal crisis and myocarditis, Nihon Toseki Igakkai Zasshi, 2010, 43, 10, 865

    CrossRef

  9. 9
    Rajeev Jain, Dwain L. Thiele, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  10. 10
    Ellen C. Ebert, Esophageal disease in progressive systemic sclerosis, Current Treatment Options in Gastroenterology, 2008, 11, 1, 64

    CrossRef

  11. 11
    Marco G. Patti, Warren J. Gasper, Piero M. Fisichella, Ian Nipomnick, Francesco Palazzo, Gastroesophageal Reflux Disease and Connective Tissue Disorders: Pathophysiology and Implications for Treatment, Journal of Gastrointestinal Surgery, 2008, 12, 11, 1900

    CrossRef

  12. 12
    D Khanna, E Melikterminas, Gastrointestinal involvement in systemic sclerosis, Indian Journal of Rheumatology, 2008, 3, 1, 13

    CrossRef

  13. 13
    Robyn Domsic, Kenneth Fasanella, Klaus Bielefeldt, Gastrointestinal Manifestations of Systemic Sclerosis, Digestive Diseases and Sciences, 2008, 53, 5, 1163

    CrossRef

  14. 14
    Carlos J Lozada, Robert W Hoffman, Management of mixed connective tissue disease, Future Rheumatology, 2008, 3, 4, 357

    CrossRef

  15. 15
    Sudish C. Murthy, Pearson's Thoracic and Esophageal Surgery, 2008,

    CrossRef

  16. 16
    Dinesh Khanna, Digestive Involvement in Systemic Autoimmune Diseases, 2008,

    CrossRef

  17. 17
    P. JANIAK, M. THUMSHIRN, D. MENNE, M. FOX, S. HALIM, M. FRIED, P. BRÜHLMANN, O. DISTLER, W. SCHWIZER, Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis – a randomized controlled, cross-over trial, Alimentary Pharmacology & Therapeutics, 2007, 26, 9
  18. 18
    Steven D. Waldman, Pain Management, 2007,

    CrossRef

  19. 19
    Isabelle Marie, Atteinte digestive au cours de la sclérodermie systémique, La Presse Médicale, 2006, 35, 12, 1952

    CrossRef

  20. 20
    Ellen C. Ebert, Esophageal Disease in Scleroderma, Journal of Clinical Gastroenterology, 2006, 40, 9, 769

    CrossRef

  21. 21
    Yolanda Braun-Moscovici, Marius Braun, Alexandra Balbir-Gurman, Daniel E Furst, Evaluation of gastrointestinal involvement in scleroderma, Future Rheumatology, 2006, 1, 5, 517

    CrossRef

  22. 22
    I. MARIE, P. DUCROTTE, P. DENIS, M. F. HELLOT, H. LEVESQUE, Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy, Alimentary Pharmacology & Therapeutics, 2006, 24, 11-12
  23. 23
    P. J. Roberts-Thomson, J. G. Walker, Scleroderma: it has been a long hard journey, Internal Medicine Journal, 2006, 36, 8
  24. 24
    H. SALLAM, T. A. MCNEARNEY, J. D. Z CHEN, Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma), Alimentary Pharmacology & Therapeutics, 2006, 23, 6
  25. 25
    Tom C. Martinsen, Kåre Bergh, Helge L. Waldum, Gastric Juice: A Barrier Against Infectious Diseases, Basic & Clinical Pharmacology & Toxicology, 2005, 96, 2
  26. 26
    J. Wipff, Y. Allanore, F. Soussi, B. Terris, V. Abitbol, J. Raymond, S. Chaussade, A. Kahan, Prevalence of Barrett's esophagus in systemic sclerosis, Arthritis & Rheumatism, 2005, 52, 9
  27. 27
    Esther Hage, Lene Hendel, Jens Gustafsen, Jakob Hendel, Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole, European Journal of Gastroenterology & Hepatology, 2003, 15, 7, 781

    CrossRef

  28. 28
    J.L. Andreu Sánchez, J. Sanz Sanz, J. Mulero Mendoza, Esclerosis sistémica (esclerodermia), Medicine - Programa de Formación Médica Continuada Acreditado, 2000, 8, 30, 1543

    CrossRef

  29. 29
    X. Bessa Caserras, V. Piñol Sánchez, A. Soriano Izquierdo, J.I. Elizalde Frez, Tratamiento médico de anomalías de la función motora esofágica y gástrica, Medicine - Programa de Formación Médica Continuada Acreditado, 2000, 8, 3, 112

    CrossRef

  30. 30
    John H. Stone, Fredrick M. Wigley, Management of systemic sclerosis: The art and science, Seminars in Cutaneous Medicine and Surgery, 1998, 17, 1, 55

    CrossRef

  31. 31
    Robert W. Sjogren, Gastrointestinal motility disorders in scleroderma, Arthritis & Rheumatism, 1994, 37, 9
  32. 32
    J. LARNER, M. I. R. HAMILTON, Review article: infective complications of therapeutic gastric acid inhibition, Alimentary Pharmacology & Therapeutics, 1994, 8, 6